Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]

1343 reported adverse events

Drugs of this class: BACILLUS CALMETTE-GUERIN

These side effects are most commonly reported by patients taking drugs of the Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] class:

# Side effect Count
0 NO ADVERSE EVENT 304
1 PRODUCT DOSE OMISSION 178
2 PRODUCT AVAILABILITY ISSUE 168
3 BLADDER CANCER RECURRENT 131
4 PYREXIA 73
5 DRUG DOSE OMISSION 66
6 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 58
7 DRUG INEFFECTIVE 52
8 PRODUCT DOSE OMISSION ISSUE 50
9 PRODUCT SUPPLY ISSUE 42
See all common reactions for Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]

Drugs of the Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLADDER GRANULOMA 4 0.3333
1 BLADDER CANCER RECURRENT 131 0.1765
2 BLADDER DYSPLASIA 2 0.1667
3 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 58 0.1620
4 RADICAL CYSTECTOMY 4 0.1538
5 EPIDIDYMITIS TUBERCULOUS 4 0.1176
6 SECONDARY TRANSMISSION 2 0.1000
7 TRANSITIONAL CELL CARCINOMA RECURRENT 2 0.0909
8 EXPOSURE TO BODY FLUID 2 0.0769
9 BOVINE TUBERCULOSIS 28 0.0765
See all enriched reactions for Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]